Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice

Vaccine

Volumn 15, Issue 3, 1997, Pages 276-280

  Chiarantini, L ^a   Argnani, R ^b   Zucchini, S ^b   Stevanato, L ^b   Zabardi, P ^b   Grossi, M P ^b   Magnani, M ^a   Manservigi, R ^b  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

adjuvant; herpes simplex virus; immunotherapy; red blood cells

Indexed keywords

HERPES SIMPLEX VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HERPES SIMPLEX; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; HERPESVIRIDAE INFECTIONS; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; VIRAL ENVELOPE PROTEINS;

EID: 0030932273     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00181-8     Document Type: Article

References (26)

1. Inglis, S.C. Challenges and progress in developing herpesvirus vaccines. TIB Tech. 1995, 13, 135-142
2. Manservigi, R., Grossi, M.P., Gualandri, R. et al. Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. J. Virol. 1990, 64, 431-436
3. Erturk, M., Phillpotts, R.J., Welch, M.J. and Jennings, R. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection. Vaccine 1991, 9, 728-734
4. Mishkin, E.M., Fahey, J.R., Kino, Y., Klein, R.J., Abramovitz, A.S. and Mento, S.J. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models. Vaccine 1991, 9, 147-153
5. Meigner, B., Jourdier, T.M., Norrild, B., Pereira, L. and Roizman, N. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus. J. Infect. Dis. 1987, 155, 921-929
6. Ho, R.J.Y., Burke, R.L. and Merigan, T.C. Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs. J. Virol. 1989, 63, 2951-2958
7. Stanberry, L.R., Myers, M.G., Stephanopoulos, D.E. and Burke, R.L. Preinfection prophylaxis with herpes simplex virus glycoprotein immunogens: factors influencing efficacy. J. Gen. Virol. 1989, 70, 3177-3185
8. Ho, R.J.Y., Burke, R.L. and Merigan, T. Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs. Vaccine 1992, 10, 209-213
9. Nakao, M., Hazama, M., Mayumi-Aono, A., Hinuma, S. and Fujisawa, Y. Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein. J. Infect. Dis. 1994, 169, 787-791
10. Langer, R. New methods of drug delivery. Science 1990, 249, 1527-1533
11. Ashley, R., Mertz, G.J. and Corey, L. Detection of asymptomatic herpes simplex virus infections after vaccination. J. Virol. 1987, 61, 264-268
12. Straus, S.E., Corey, L., Burke, R.L. et al. Placebo-controlled trial of vaccination with recominant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 1994, 343, 1460-1463
13. Zheng, B., Graham, F.L., Johnson, D.C., Hanke, T., McDermott, M.R. and Prevec, L. Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors. Vaccine 1993, 11, 1191-1198
14. Johnson, D.C. Adenovirus vectors as potential vaccines against herpes simplex virus. Rev. Infect. Dis. 1991, 13, 912-916
15. Aurelian, L., Smith, C.C., Wachsman, M. and Paoletti, E. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D. Rev. Infect. Dis. 1991, 13, 924-934
16. Magnani, M., Chiarantini, L., Vittoria, E., Mancini, U., Rossi, L. and Fazi, A. Red blood cells as an antigen delivery system. Biotech. Appl. Biochem. 1992, 16, 188-194
17. Manservigi, R., Incorvaia, C., Di Luca, D. et al. Experimental keratitis in rabbits by human HSV-1 variants: prevention and treatment. J. Med. Virol. 1990, 32, 148-154
18. Hunter, W.M. and Greenwood, F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962, 194, 495-496
19. Magnani, M., Chiarantini, L. and Mancini, U. Preparation and characterization of biotinylated red blood cells. Biotech. Appl. Biochem. 1994, 20, 335-345
20. Revello, M.G., Gualandri, R., Manservigi, R. and Gerna, G. Development and evaluation of an ELISA using secreted recombinant glycoprotein B for determination of IgG antibody to herpes simplex virus. J. Virol. Meth. 1991, 34, 57-70
21. Manservigi, R., Gualandri, R., Negrini, M. et al. Constitutive expression in human cells of herpes simplex virus type 1 glycoprotein B gene cloned in an episomal eukaryotic vector. Virology 1988, 167, 284-288
22. Muggeridge, M.I., Roberts, S.R., Isola, V.J., Cohen, G.H. and Eisenberg, R.J. Herpes simplex virus. In: Immunochemistry of Viruses, II. The Basis for Serodiagnosis and Vaccines (Eds van Regenmortel, M.H.V. and Neurath, A.R.). Elsevier Science Publishers B.V., Amsterdam, 1990, pp. 459-481
23. Perraut, R., Hundt, E., Garraud, O., Enders, B. and Gysin, J. Comparison of the effects of adjuvant doses on the quantitative and qualitative antibody response to selected antigens in New World squirrel monkeys Saimiri sciureus. Vaccine 1993, 11, 730-736
24. Allison, A.C. and Byars, N.E. Immunological adjuvants: desiderable properties and side-effects. Mol. Immun. 1991, 28, 279-284
25. Benacerraf, B., Falo, L.D. and Rock, K.L. In: Processing and Presentation of Antigens (Eds. Pernis, B., Silverstein, S.C. and Vogel, N.J.). Academic Press, New York, 1988, pp. 3-11
26. Stanberry, L.R. Herpes simplex virus vaccines as immuno-therapeutic agents. Trends Microbiol. 1995, 3, 244-247